معرفی
Min Li, PhD, is a Professor at the University of Oklahoma Health Sciences Center, holding multiple leadership roles including George Lynn Cross Research Professor, Virginia Kerley Cade Endowed Chair in Cancer Treatment, Assistant Dean for International Research Collaboration (College of Medicine), Vice Chair for Research (Department of Medicine), and Associate Director for Global Oncology (Stephenson Cancer Center). As Co-Leader of the Cancer Biology Program at Stephenson Cancer Center, President of the American Pancreatic Association, and Editor-in-Chief of Cancer Letters, Dr. Li is a foremost expert in pancreatic cancer pathogenesis.
- Education: BS (Shandong University, 1994), MS (Chinese Academy of Medical Science, 1997), PhD (Emory University, 2002)
Dr. Li's research focuses on pancreatic cancer mechanisms, particularly the role of zinc transporter ZIP4, microRNA functions, cancer metabolism, and genomic sequencing. Their lab pioneered ZIP4's identification as a key oncogenic driver and developed shRNA-based therapies. With over 120 publications and NIH R01/R21 grants, Dr. Li mentors postdocs, students, and residents globally.
- Scientific Leadership: President of American Pancreatic Association
- Editorial Roles: Editor-in-Chief of Cancer Letters
- Endowments: George Lynn Cross Research Professor; Virginia Kerley Cade Endowed Chair
Dr. Li's work combines basic science with clinical translation, serving as a member of NIH study sections and editorial boards across prestigious journals.
